Rates of treated schizophrenia and its clinical and cultural features in the population isolate of the Iban of Sarawak: a tri-diagnostic approach.

نویسندگان

  • Robert Barrett
  • Peter Loa
  • Edward Jerah
  • Derek Nancarrow
  • David Chant
  • Bryan Mowry
چکیده

BACKGROUND We present results of a study of treated rates of schizophrenia among the Iban of Sarawak, Malaysia. Most Iban live in longhouses, each comprising a kindred group of up to 300 individuals. Cultural practices such as minimal intermarriage with members of adjacent ethnic groups and in-depth genealogical knowledge make them a population suitable for genetic investigation. Iban culture is conducive to a focus on symptoms and illness, and to patterns of treatment-seeking behaviour that are enthusiastic and persistent. METHOD We identified all known cases of psychotic disorder within a defined catchment area based on an exhaustive survey of available medical records. From corresponding Malaysian census data (91,056 persons), we report rates of treated schizophrenia in the Iban population, using three diagnostic systems, as well as the demographic and clinical characteristics of these individuals. RESULTS The most frequent presenting complaints were insomnia and aggression. We found higher treated rates for narrowly defined schizophrenia among males, but no significant gender difference for age of onset. Estimates of treated rates to age 55 years (per 10,000) for narrow schizophrenia were 41.9 (ICD-10), 56.5 (DSM-IV), and 83 (RDC), while the rates for broad schizophrenia were 105.5, 103.2, and 107.5 respectively. CONCLUSIONS Treated rates of schizophrenia were higher than the reported prevalence for many populations at risk, including many small-scale societies, although different methodological approaches may partly explain these findings. Given the cultural patterns of Iban treatment-seeking behaviour, treated rates of schizophrenia reported here may closely approximate the population prevalence of this disorder.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Study of the association between DRD2 Gene Ser311Cys and GSTM1 Gene polymorphism in Schizophrenia

Introduction: Schizophrenia is a mental disorder affecting 1% of the world's population. Two of genes have been recognized to be involved in development of this disease: DRD2 and GSTM1. Methods: This case-control study included 100 patients suffering from schizophrenia who referred to Yazd Neuropsychiatry Hospital. Also, 100 healthy patients without schizophrenia were selected as the control g...

متن کامل

مقایسه آزمون وسواسی- اجباری مادزلی و مصاحبه بالینی ساختاریافته مبتنی بر DSM-IV برای تشخیص اختلال وسواسی- اجباری در بیماران مبتلا به اسکیزوفرنیا

 AbstractObjectives: This study plans to determine diagnostic features and the best cut-off point in Maudsley Obsessive-Compulsive Inventory for patients with schizophrenia. Method: In a cross-sectional study, 96 inpatients (56 men and 40 women) with schizophrenia (based on DSM-IV diagnostic criteria) were selected from Iran Psychiatry Hospital (in Tehran) by convenient sampling and screened fo...

متن کامل

Treatment-Responsiveness of Negative Symptoms in Schizophrenia: A double-blind placebo-control clinical trial

Background: The negative symptoms of schizophrenia remain a major clinical challenge. Nortriptyline is a serotonin and noradrenalin reuptake inhibitor and belongs to secondary amine tricycles. The aim of this study is to evaluate the effect of nortriptyline on the negative symptoms of schizophrenia. Methods: This study is a six-week randomized placebo-control trial of nortriptyline or placebo a...

متن کامل

بررسی میزان و عوامل مؤثر بر تغییر تشخیص اختلالات خلقی به اسکیزوفرنیا پس از شش سال

Introduction: The purpose of this study was to assess prevalence and possible variables on the change of diagnosis in mood disorder patients to schizophrenia. Methods: This study was a retrospective and comparative analytic research that was performed in 2006 at Razi psychiatric hospital. The study included all of the 176 patients who were hospitalized in 2000 with diagnosis of a mood disorder...

متن کامل

Effects of Bromocriptine on Negative Symptoms of Schizophrenia: A Double Blind Clinical Trial

Negative symptoms are still a major obstacle in the recovery of schizophrenic patients. Many attempts to develop novel drugs affecting negative symptoms of schizophrenia have yielded insignificant results. This study evaluates the effects of bromocriptine, a dopamine agonist, on negative symptoms of schizophrenia utilizing a placebo-controlled crossover double-blind clinical trial. Methodology:...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Psychological medicine

دوره 35 2  شماره 

صفحات  -

تاریخ انتشار 2005